Continuous versus Intermittent Glycemic Monitoring in Elective Surgery: Analytical Performance and Intraoperative Efficacy of Continuous Glucose Monitoring Systems — A Systematic Review and Meta-Analysis
This systematic review and meta-analysis of ten studies involving 557 adults demonstrates that subcutaneous continuous glucose monitoring systems offer clinically acceptable intraoperative accuracy and significantly improve glycemic control by detecting more hypoglycemic events and increasing time in range compared to conventional intermittent monitoring.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the operating room, the body is under siege. Even a routine surgery triggers a cascade of stress responses that can send blood sugar soaring, while the fasting required before the procedure and the drugs used to keep a patient asleep can cause it to crash dangerously low. For decades, anesthesiologists have managed this delicate balance by pricking a finger or drawing a small amount of blood every hour or two. This method, while standard, is like checking the weather only once a day; it misses the sudden storms and clearings that happen in between. The goal has always been to keep blood sugar within a safe, narrow band, but the gaps in monitoring meant that silent, dangerous drops or spikes could go unnoticed until it was too late.
A new approach has emerged from the world of diabetes care: a small sensor placed under the skin that measures glucose levels continuously, updating every few minutes. This technology offers a constant stream of data, promising to turn a reactive approach into a proactive one. However, the operating room is a harsh environment for such delicate electronics. The body's temperature can be lowered drastically, blood flow can be redirected, and the physiology of a patient under anesthesia is far more volatile than that of someone walking around their home. The question facing the medical community was whether these sensors could survive the rigors of surgery and provide accurate enough information to guide life-or-death decisions.
To answer this, a team of researchers conducted a comprehensive review of ten recent studies involving over five hundred adults undergoing elective surgery. They gathered data from randomized trials and prospective observations to see how well these continuous sensors performed compared to the traditional finger-prick method. The researchers focused on two main things: how accurately the sensors measured glucose levels against the gold-standard blood tests, and whether using them actually helped keep patients' blood sugar within the safe target range during the operation.
The results painted a picture of a technology that is largely successful but has specific limits. When the researchers combined the data from the various studies, they found that the continuous sensors were generally accurate enough for clinical use. On average, the difference between the sensor reading and the actual blood sugar level was about fourteen percent. While this might sound like a large margin, in the context of medical monitoring, it is considered acceptable for making treatment decisions. The sensors were particularly reliable during standard abdominal surgeries and other non-cardiac procedures, where the body's internal environment remained relatively stable. In these settings, the sensors successfully identified a significant number of low blood sugar events that the traditional, intermittent checks completely missed. In one study of seventy patients, the continuous sensors detected dangerous drops in blood sugar in forty-three percent of the patients, whereas the standard monitoring protocol failed to identify a single one of these episodes.
However, the story changes when the surgery involves the heart. The researchers found that the sensors struggled significantly during cardiac procedures that required cooling the patient's body and using a heart-lung machine. In these extreme conditions, the accuracy of the sensors dropped, with the difference between the sensor and the blood test rising to nearly twenty percent. The cold temperatures and the artificial circulation disrupted the way the sensors measured glucose in the tissue just under the skin. This suggests that while the technology is a powerful tool for most surgeries, it cannot yet be fully trusted as the sole source of truth during the most complex and physiologically disruptive heart operations.
Beyond accuracy, the review looked at whether using these sensors actually improved patient outcomes. The data showed a clear benefit: patients monitored with continuous sensors spent significantly more time with their blood sugar in the ideal range compared to those monitored with the traditional method. The improvement was substantial, with the continuous monitoring group spending nearly fifteen percent more of the surgery time within the safe zone. This shift implies that anesthesiologists could make better, faster adjustments to insulin or glucose infusions if they had a real-time view of the patient's metabolic state, rather than waiting for the next scheduled blood draw.
The study also confirmed that the technology is safe for use in the operating room. Across all the studies, there were no serious adverse events linked to the sensors themselves. The devices stayed attached and functional for the vast majority of the surgery, with availability rates exceeding ninety-six percent in most cases. The few technical issues that did arise were mostly related to the initial warm-up period of the sensor or minor skin irritation, rather than any failure that would endanger the patient.
Ultimately, this review suggests that continuous glucose monitoring is a viable and valuable addition to the anesthesiologist's toolkit for most elective surgeries. It offers a level of vigilance that intermittent checks simply cannot provide, catching hidden dangers and keeping patients in a safer metabolic zone. Yet, the findings also serve as a cautionary note. The technology is not a magic replacement for all traditional methods, especially in the most extreme surgical environments where the body's physiology is pushed to its limits. For now, the best approach appears to be using these sensors as a sophisticated guide that complements, rather than replaces, the established practices of blood testing, ensuring that patients receive the most accurate care possible regardless of the complexity of their surgery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.